Literature DB >> 20847229

Regulation of Nur77 expression by β-catenin and its mitogenic effect in colon cancer cells.

Hua Wu1, Yayu Lin, Wengang Li, Zhe Sun, Weiwei Gao, Haiping Zhang, Lei Xie, Fuquan Jiang, Bin Qin, Tingdong Yan, Liqun Chen, Yi Zhao, Xihua Cao, Yin Wu, Bingzhen Lin, Hu Zhou, Alice Sze-Tsai Wong, Xiao-Kun Zhang, Jin-Zhang Zeng.   

Abstract

The orphan nuclear receptor Nur77 is an immediate-early response gene whose expression is rapidly induced by various extracellular stimuli. The aims of this study were to study the role of Nur77 expression in the growth and survival of colon cancer cells and the mechanism by which Nur77 expression was regulated. We showed that levels of Nur77 were elevated in a majority of human colon tumors (9/12) compared to their nontumorous tissues and that Nur77 expression could be strongly induced by different colonic carcinogens including deoxycholic acid (DCA). DCA-induced Nur77 expression resulted in up-regulation of antiapoptotic BRE and angiogenic VEGF, and it enhanced the growth, colony formation, and migration of colon cancer cells. In studying the mechanism by which Nur77 was regulated in colon cancer cells, we found that β-catenin was involved in induction of Nur77 expression through its activation of the transcriptional activity of AP-1 (c-Fos/c-Jun) that bound to and transactivated the Nur77 promoter. Together, our results demonstrate that Nur77 acts to promote the growth and survival of colon cancer cells and serves as an important mediator of the Wnt/β-catenin and AP-1 signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20847229      PMCID: PMC3005431          DOI: 10.1096/fj.10-166462

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  62 in total

Review 1.  Wnt/beta-catenin signaling in development and disease.

Authors:  Hans Clevers
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

2.  Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer.

Authors:  Vijaykumar R Holla; Jason R Mann; Qiong Shi; Raymond N DuBois
Journal:  J Biol Chem       Date:  2005-11-17       Impact factor: 5.157

3.  Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.

Authors:  Susanne Dihlmann; Matthias Kloor; Christine Fallsehr; Magnus von Knebel Doeberitz
Journal:  Carcinogenesis       Date:  2005-05-11       Impact factor: 4.944

4.  The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.

Authors:  Ulrike Stein; Franziska Arlt; Wolfgang Walther; Janice Smith; Todd Waldman; Erik D Harris; Susan D Mertins; Claus W Heizmann; David Allard; Walter Birchmeier; Peter M Schlag; Robert H Shoemaker
Journal:  Gastroenterology       Date:  2006-08-22       Impact factor: 22.682

Review 5.  Targeting Nur77 translocation.

Authors:  Xiao-kun Zhang
Journal:  Expert Opin Ther Targets       Date:  2007-01       Impact factor: 6.902

6.  beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

Authors:  T Brabletz; A Jung; S Dag; F Hlubek; T Kirchner
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

7.  c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.

Authors:  Jing Liu; Yuzuru Minemoto; Anning Lin
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

8.  Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.

Authors:  B Mann; M Gelos; A Siedow; M L Hanski; A Gratchev; M Ilyas; W F Bodmer; M P Moyer; E O Riecken; H J Buhr; C Hanski
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Deoxycholic acid induces intracellular signaling through membrane perturbations.

Authors:  Samira Jean-Louis; Sandeep Akare; M Ahad Ali; Eugene A Mash; Emmanuelle Meuillet; Jesse D Martinez
Journal:  J Biol Chem       Date:  2006-03-17       Impact factor: 5.157

10.  JNK2 is a positive regulator of the cJun transcription factor.

Authors:  Anja Jaeschke; Maria Karasarides; Juan-Jose Ventura; Anka Ehrhardt; Chao Zhang; Richard A Flavell; Kevan M Shokat; Roger J Davis
Journal:  Mol Cell       Date:  2006-09-15       Impact factor: 17.970

View more
  52 in total

1.  Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling.

Authors:  Pamela A Marshall; Zachary Hernandez; Ichiro Kaneko; Tim Widener; Christa Tabacaru; Izayadeth Aguayo; Peter W Jurutka
Journal:  J Steroid Biochem Mol Biol       Date:  2012-05-14       Impact factor: 4.292

Review 2.  Orphan Nuclear Receptors in Colorectal Cancer.

Authors:  Michael E Kelly; Helen M Mohan; Alan W Baird; Elizabeth J Ryan; Des C Winter
Journal:  Pathol Oncol Res       Date:  2018-06-28       Impact factor: 3.201

3.  Nur77 limits endothelial barrier disruption to LPS in the mouse lung.

Authors:  Ni Zhu; Guan-Xin Zhang; Bing Yi; Zhi-Fu Guo; Soohwa Jang; Yongqiang Yin; Fan Yang; Ross Summer; Jianxin Sun
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-08-28       Impact factor: 5.464

4.  Inhibition of NR4A1 Promotes ROS Accumulation and IL24-Dependent Growth Arrest in Rhabdomyosarcoma.

Authors:  Erik Hedrick; Kumaravel Mohankumar; Alexandra Lacey; Stephen Safe
Journal:  Mol Cancer Res       Date:  2019-08-28       Impact factor: 5.852

5.  BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway.

Authors:  Xihua Cao; Liqun Chen; Xiaohui Chen; Xuhuang Tu; Gulimiran Alitongbieke; Zebin Xia; Xiaotong Li; Ziwen Chen; Meimei Yin; Dan Xu; Shangjie Guo; Zongxi Li; Xindao Zhang; Dingyu Xu; Meichun Gao; Jie Liu; Zhiping Zeng; Hu Zhou; Ying Su; Xiao-Kun Zhang
Journal:  Mol Cancer Ther       Date:  2019-03-29       Impact factor: 6.261

6.  NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.

Authors:  Erik Hedrick; Syng-Ook Lee; Ravi Doddapaneni; Mandip Singh; Stephen Safe
Journal:  Mol Cell Biol       Date:  2016-04-15       Impact factor: 4.272

7.  Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer.

Authors:  Kumaravel Mohankumar; Xi Li; Subhashree Sridharan; Keshav Karki; Stephen Safe
Journal:  Gynecol Oncol       Date:  2019-04-30       Impact factor: 5.482

8.  Nuclear receptor 4A (NR4A) family - orphans no more.

Authors:  Stephen Safe; Un-Ho Jin; Benjamin Morpurgo; Ala Abudayyeh; Mandip Singh; Ronald B Tjalkens
Journal:  J Steroid Biochem Mol Biol       Date:  2015-04-23       Impact factor: 4.292

9.  Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.

Authors:  Syng-Ook Lee; Xi Li; Erik Hedrick; Un-Ho Jin; Ronald B Tjalkens; Donald S Backos; Li Li; Yi Zhang; Qiao Wu; Stephen Safe
Journal:  Mol Endocrinol       Date:  2014-08-06

Review 10.  Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.

Authors:  Stephen Safe; Un-Ho Jin; Erik Hedrick; Alexandra Reeder; Syng-Ook Lee
Journal:  Mol Endocrinol       Date:  2013-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.